MINI FUTURE LONG - VIRBAC Stock

Certificat

DE000MD6C8W2

Delayed Börse Stuttgart 09:15:58 2024-05-23 EDT
20.63 EUR -0.05% Intraday chart for MINI FUTURE LONG - VIRBAC
Current month+4.93%
1 month-7.90%
Date Price Change
24-05-23 20.63 -0.05%
24-05-22 20.64 +0.49%
24-05-21 20.54 +2.85%
24-05-20 19.97 -2.82%
24-05-17 20.55 -3.66%

Delayed Quote Börse Stuttgart

Last update May 23, 2024 at 09:15 am

More quotes

Static data

Product typeCertificat Turbo Stop Loss
Buy / SellCALL
Underlying VIRBAC
Issuer Morgan Stanley
WKN MD6C8W
ISINDE000MD6C8W2
Date issued 2022-07-18
Strike 152.4
Maturity Unlimited
Parity 10 : 1
Emission price 21.46
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 24.4
Lowest since issue 8.14

Company Profile

Virbac specializes in the research, production and marketing of veterinary medicines. The activity is organized around 2 product families: - pet medications: pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications: pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: France (15.4%), Europe (26.2%), Latin America (17.1%), Asia (16.4%), North America (13.2%), Pacific (9.3%), Africa and Middle East (2.4%).
Sector
-
More about the company

Ratings for Virbac

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Virbac

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
361 EUR
Average target price
372.4 EUR
Spread / Average Target
+3.17%
Consensus